This article is based on a poster originally authored by Sanaz Koosha, Manpreet Singh, Eva Van Lombergen, Bieke Soen, Matthias De Decker, Leen Catrysse and Nithianandan Selliah. Precise ...
LBL-034 is an investigational GPRC5D-targeted CD3 bispecific antibody. The Food and Drug Administration (FDA) has granted Orphan Drug designation to LBL-034 for the treatment of multiple myeloma.
Antengene Corporation Limited ("Antengene", SEHK: 6996.HK) , a leading innovative, commercial-stage global biotech company ded ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results